© 2022 MJH Life Sciences™ and Contagion Live. All rights reserved.
Latest Conference Articles
The Patient Impact of CDI, Preventing Reoccurrence
June 1st 2022, 12:00pm
A clinician discusses the disease burden of reoccurring CDI, but sees a silver lining in the new investigational therapies potentially changing the treatment paradigm for the better.
The Next Big Thing in Stewardship?
May 29th 2022, 3:58pm
A clinician is advocating for incorporating diagnostic stewardship practices within antimicrobial stewardship programs, which could someday lead to best practice guidelines on a larger scale.
Rapid Diagnostic Testing’s Impact on Timing to Optimal Therapy
May 27th 2022, 1:59pm
Utilizing a newer technology, investigators wanted to see if a reduction in time led to clinically significant antimicrobial adjustments.
Measuring the Effectiveness of a Novel Antibiotic for Patients with Nontuberculous Mycobacterial Infections
May 27th 2022, 12:16pm
A multicenter study looked at treating these infections with omadacycline.
Monoclonal Antibody ADG20 Neutralizes COVID-19 Variants
May 26th 2022, 6:09pm
MAD-ID | Making a Difference in Infectious Diseases
The investigational, fully human IgG1 monoclonal antibody ADG20 prevented and treated infection with COVID-19 variants of concern.
Monitoring Vancomycin Area Under the Curve Dosing
May 26th 2022, 11:52am
A medical center wanted to review prescribing and documentation practices for their pharmacists.
Investigating RBX2660 for Recurrent C Difficile Infection
May 24th 2022, 6:00pm
MAD-ID | Making a Difference in Infectious Diseases
RBX2660, an investigational microbiota-based live biotherapeutic for the treatment of C difficile, safely and effectively reduced recurrent C diff for 6 months.
Examining Oral Vancomycin as a First-Line CDI Therapy
May 24th 2022, 5:22pm
With limitations on fidaxomicin at their facility, a hospital looked at vancomycin usage to determine if they needed to align with the new IDSA/SHEA CDI treatment guideline.
Assessing Vancomycin and Metronidazole Susceptibility for CDI
May 23rd 2022, 6:15pm
A team of investigators studied Clostridioides difficile infection (CDI) isolates to gauge resistance in the 2 antibiotics.
The Role of a Stewardship Pharmacist in Treating UTIs in the Outpatient Setting
May 22nd 2022, 5:00pm
A health system piloted a program that explored having an infectious disease pharmacist aid in guiding treatment.
Latest News
CDC Director Endorses ACIP Recommendation for Moderna COVID-19 Vaccine for Children and Adolescents
“Long COVID” Caused by High Levels of Virus-Specific T Cells
“Doing Quality Work, With Rigor”: Designing the Next Generation Pneumococcal Vaccine
CDC Identifies Adenovirus Infections in 45% of Acute Hepatitis Cases in Children